Ella Donegan > Goodwin > London, England > Lawyer Profile
Goodwin Offices

Sancroft, 10-15 Newgate Street
London
EC1A 7AZ
England
- Firm Profile
- Go to...
Ella Donegan

Position
Associate
Career
Ella Donegan is an associate in Goodwin’s Technology and Life Sciences groups in London. Ella advises clients on a range of corporate matters, with a particular focus on transactions in the technology sector. Her experience includes advising investors, companies (ranging from start-ups to large multi-nationals), and management teams on a broad variety of projects including venture capital, mergers & acquisitions, and general corporate transactions. Prior to becoming a solicitor, Ella worked as a medical doctor in the National Health Service.
Education
Legal Practice Course, 2014, Kaplan Law School; Graduate Diploma in Law, 2013, BPP Law School; Bachelor of Medicine, 2009, University College London
Lawyer Rankings
London > Corporate and commercial > Venture capital
Representing a host of start-ups, emerging growth companies, and late-stage mature corporates, the Goodwin team leverages its ‘strong market knowledge’ to advise on high-value fundraisings and seed rounds. The practice boasts in-depth expertise across healthcare, AI, and environmental matters, often working closely with the firm’s private equity division to support clients in growth equity transactions and complex exits. The team is chaired by David Mardle, an expert in capital markets transactions. Sophie McGrath utilises her ‘vast dealmaking experience’ in private and public financings. Both Andrew Davis and Andrew Harrow primarily focus on joint ventures and growth capital financings. Based in Cambridge, Elizabeth Rhodes and Adam Thatcher are noted for their M&A expertise. Other key figures include Kenny Walker-Durrant, who regularly acts for venture capital investors, as well as Richard Bloomfield and Ella Donegan. Ali Ramadan left to join Cooley (UK) LLP in September 2024.
Lawyer Rankings
Top Tier Firm Rankings
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > EU and competition
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Investment fund formation and management > Real estate funds
- Corporate and commercial > Venture capital
Firm Rankings
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Investment fund formation and management > Private funds
- Real estate > Commercial property: investment
- TMT (technology, media and telecoms) > Fintech: corporate and commercial
- Industry focus > Hospitality and leisure
- Industry focus > Life sciences and healthcare
- Finance > Acquisition finance
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Finance > Corporate restructuring & insolvency
- Risk advisory > Data protection, privacy and cybersecurity
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > Private equity: transactions – high-value deals (£500m+)
- Real estate > Property finance
- Dispute resolution > Commercial litigation: premium
- Employment > Employers
- Corporate and commercial > EU and competition
- Corporate and commercial > Equity capital markets – small-mid cap
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)